Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Thorax. 2015 Apr 24;71(3):223–229. doi: 10.1136/thoraxjnl-2014-206750

Figure 4. Lung function by immediate FEV1 response with treatment.

Figure 4

FEV1 % of predicted mean ± 1SD for participants with <10% relative FEV1 (L) response during PEx treatment (black lines, n=35) and participants ≥10% relative FEV1 (L) response during treatment (gray lines, n=67): best during 6 months before study PEx, at time of IV initiation for PEx, at end of IV for PEx, and best during 3 months after study PEx.